Ho JH - Search Results

1

Nasopharyngeal carcinoma (NPC).

Ho JH. Ho JH. Adv Cancer Res. 1972;15:57-92. doi: 10.1016/s0065-230x(08)60372-3. Adv Cancer Res. 1972. PMID: 4333791 Review. No abstract available.

2

Prognostic value of EBV markers in the clinical management of nasopharyngeal carcinoma (NPC): a multicenter follow-up study.

de-Vathaire F, Sancho-Garnier H, de-Thé H, Pieddeloup C, Schwaab G, Ho JH, Ellouz R, Micheau C, Cammoun M, Cachin Y, et al. de-Vathaire F, et al. Among authors: ho jh. Int J Cancer. 1988 Aug 15;42(2):176-81. doi: 10.1002/ijc.2910420206. Int J Cancer. 1988. PMID: 2841245

3

Immunogenetic aspects of nasopharyngeal carcinoma. V. Confirmation of a Chinese-related HLA profile (A2, Singapore 2) associated with an increased risk in Chinese for nasopharyngeal carcinoma.

Simons MJ, Wee GB, Singh D, Dharmalingham S, Yong NK, Chau JC, Ho JH, Day NE, De-Thé G. Simons MJ, et al. Among authors: ho jh. Natl Cancer Inst Monogr. 1977 Dec;47:147-51. Natl Cancer Inst Monogr. 1977. PMID: 613233

4

Nasopharyngeal carcinoma: significance of changes in Epstein-Barr virus-related antibody patterns following therapy.

Henle W, Ho JH, Henle G, Chau JC, Kwan HC. Henle W, et al. Among authors: ho jh. Int J Cancer. 1977 Nov 15;20(5):663-72. doi: 10.1002/ijc.2910200504. Int J Cancer. 1977. PMID: 200569 No abstract available.

5

Neutralizing EBV-specific IgA in throat washings of nasopharyngeal carcinoma (NPC) patients.

Desgranges C, De-Thé G, Ho JH, Ellouz R. Desgranges C, et al. Among authors: ho jh. Int J Cancer. 1977 May 15;19(5):627-33. doi: 10.1002/ijc.2910190506. Int J Cancer. 1977. PMID: 193801

6

Cold lymphocytotoxic antibodies in nasopharyngeal carcinoma.

Lamelin JP, Revillard JP, Chalopin JM, Ho JH, Souissi T, Schwaab G, De-Thé G. Lamelin JP, et al. Among authors: ho jh. Br J Cancer. 1977 Apr;35(4):426-32. doi: 10.1038/bjc.1977.64. Br J Cancer. 1977. PMID: 192260 Free PMC article.

7

Nasopharyngeal carcinoma. IX. Antibodies to EBNA and correlation with response to other ebv antigens in chinese patients.

de-Thé G, Ho JH, Ablashi DV, Day NE, Macario AJ, Martin-Berthelon MC, Pearson G, Sohier R. de-Thé G, et al. Among authors: ho jh. Int J Cancer. 1975 Nov 15;16(5):713-21. doi: 10.1002/ijc.2910160503. Int J Cancer. 1975. PMID: 171226

8

Establishment of a cell line (NPC/HK1) from a differentiated squamous carcinoma of the nasopharynx.

Huang DP, Ho JH, Poon YF, Chew EC, Saw D, Lui M, Li CL, Mak LS, Lai SH, Lau WH. Huang DP, et al. Among authors: ho jh. Int J Cancer. 1980 Aug;26(2):127-32. doi: 10.1002/ijc.2910260202. Int J Cancer. 1980. PMID: 6259064

9

Demonstration of Epstein-Barr virus-associated nuclear antigen in nasopharyngeal carcinoma cells from fresh biopsies.

Huang DP, Ho JH, Henle W, Henle G. Huang DP, et al. Among authors: ho jh. Int J Cancer. 1974 Nov 15;14(5):580-8. doi: 10.1002/ijc.2910140504. Int J Cancer. 1974. PMID: 4142471 No abstract available.

10

Nasopharyngeal carcinoma. IV. Evolution of complement-fixing antibodies during the course of the disease.

De-Thé G, Sohier R, Ho JH, Freund R. De-Thé G, et al. Among authors: ho jh. Int J Cancer. 1973 Sep 15;12(2):368-77. doi: 10.1002/ijc.2910120208. Int J Cancer. 1973. PMID: 4599785 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results